Literature DB >> 18172567

Safety and efficacy of frameless and frame-based intracranial biopsy techniques.

R Dammers1, I K Haitsma, J W Schouten, J M Kros, C J J Avezaat, A J P E Vincent.   

Abstract

BACKGROUND: Frameless stereotaxy or neuronavigation has evolved into a feasible technology to acquire intracranial biopsies with good accuracy and little mortality. However, few studies have evaluated the diagnostic yield, morbidity, and mortality of this technique as compared to the established standard of frame-based stereotactic brain biopsy. We report our experience of a large number of procedures performed with one or other technique. PATIENTS AND METHODS: We retrospectively assessed 465 consecutive biopsies done over a ten-year time span; Data from 391 biopsies (227 frame-based and 164 frameless) were available for analysis. Patient demographics, peri-operative characteristics, and histological diagnosis were reviewed and then information was analysed to identify factors associated with the biopsy not yielding a diagnosis and of it being followed by death.
RESULTS: On average, nine tissue samples were taken with either stereotaxy technique. Overall, the biopsy led to a diagnosis on 89.4% of occasions. No differences were found between the two biopsy procedures. In a multiple regression analysis, it was found that left-sided lesions were less likely to result in a non-diagnostic tissue sample (p = 0.023), and cerebellar lesions showed a high risk of negative histology (p = 0.006). Postoperative complications were seen after 12.1% of biopsies, including 15 symptomatic haemorrhages (3.8%). There was not a difference between the rates of complication after either a frame-based or a frameless biopsy. Overall, peri-operative complications (p = 0.030) and deep-seated lesions (p = 0.060) increased the risk of biopsy-related death. Symptomatic haemorrhages resulting in death (1.5% of all biopsies) were more frequently seen after biopsy of a fronto-temporally located lesion (p = 0.007) and in patients with a histologically confirmed lymphoma (p = 0.039).
CONCLUSIONS: The diagnostic yield, complication rates, and biopsy-related mortality did not differ between a frameless biopsy technique and the established frame-based technique. The site of the lesion and the occurrence of a peri-operative complication were associated with the likelihood of failure to achieve a diagnosis and with death after biopsy. We believe that using intraoperative frozen section or cytologic smear histology is essential during a stereotactic biopsy in order to increase the diagnostic yield and to limit the number of biopsy specimens that need to be taken.

Entities:  

Mesh:

Year:  2008        PMID: 18172567     DOI: 10.1007/s00701-007-1473-x

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  43 in total

1.  Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies.

Authors:  Georg Widhalm; Georgi Minchev; Adelheid Woehrer; Matthias Preusser; Barbara Kiesel; Julia Furtner; Aygül Mert; Antonio Di Ieva; Boguslaw Tomanek; Daniela Prayer; Christine Marosi; Johannes A Hainfellner; Engelbert Knosp; Stefan Wolfsberger
Journal:  Neurosurg Rev       Date:  2012-03-10       Impact factor: 3.042

2.  Sensitivity analysis aimed at blood vessels detection using interstitial optical tomography during brain needle biopsy procedures.

Authors:  Julien Pichette; Andréanne Goyette; Fabien Picot; Marie-Andrée Tremblay; Gilles Soulez; Brian C Wilson; Frédéric Leblond
Journal:  Biomed Opt Express       Date:  2015-10-05       Impact factor: 3.732

3.  Interstitial imaging with multiple diffusive reflectance spectroscopy projections for in vivo blood vessels detection during brain needle biopsy procedures.

Authors:  Fabien Picot; Andréanne Goyette; Sami Obaid; Joannie Desroches; Simon Lessard; Marie-André Tremblay; Mathias Strupler; Brian Wilson; Kevin Petrecca; Gilles Soulez; Frédéric Leblond
Journal:  Neurophotonics       Date:  2019-04-23       Impact factor: 3.593

4.  Real-time MR-guided brain biopsy using 1.0-T open MRI scanner.

Authors:  Xiangmeng He; Ming Liu; Chao Liu; Jing Fang; Yujun Xu; Ligang Wang; Jianfeng Xiang; Roberto Blanco Sequeiros; Chengli Li
Journal:  Eur Radiol       Date:  2018-06-12       Impact factor: 5.315

5.  Brain biopsy in benign neurological disease.

Authors:  C E Gilkes; S Love; R J Hardie; R J Edwards; N J Scolding; C M Rice
Journal:  J Neurol       Date:  2012-02-24       Impact factor: 4.849

Review 6.  Accuracy of percentage of signal intensity recovery and relative cerebral blood volume derived from dynamic susceptibility-weighted, contrast-enhanced MRI in the preoperative diagnosis of cerebral tumours.

Authors:  Ananya Chakravorty; Timothy Steel; Joga Chaganti
Journal:  Neuroradiol J       Date:  2015-10-16

7.  Comparative effectiveness of frame-based, frameless, and intraoperative magnetic resonance imaging-guided brain biopsy techniques.

Authors:  Yi Lu; Cecil Yeung; Alireza Radmanesh; Robert Wiemann; Peter M Black; Alexandra J Golby
Journal:  World Neurosurg       Date:  2014-08-01       Impact factor: 2.104

Review 8.  Recent technological advances in pediatric brain tumor surgery.

Authors:  Bassel Zebian; Francesco Vergani; José Pedro Lavrador; Soumya Mukherjee; William John Kitchen; Vita Stagno; Christos Chamilos; Benedetta Pettorini; Conor Mallucci
Journal:  CNS Oncol       Date:  2016-12-21

9.  Frameless stereotactic procedures in pediatric patients: safety and diagnostic efficacy.

Authors:  Mary G Parreño; Xiao Bo; Okezie O Kanu; Shlomi Constantini; Andrew A Kanner
Journal:  Childs Nerv Syst       Date:  2011-06-10       Impact factor: 1.475

10.  Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre.

Authors:  Ruben Dammers; Joost W Schouten; Iain K Haitsma; Arnaud J P E Vincent; Johan M Kros; Clemens M F Dirven
Journal:  Acta Neurochir (Wien)       Date:  2010-08-01       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.